Geneoscopy
What is Geneoscopy?
Geneoscopy is the developer of next-generation diagnostics designed to treat digestive diseases and offer cancer screening. The company’s diagnostics help in consistently extracting stool-derived eukaryotic RNA (seRNA) transcripts and detecting changes in gene expression, enabling doctors to better prevent, detect, and guide treatment for gastrointestinal disease.
Company Leadership
Erica Barnell
Chief Scientific Officer
Geneoscopy co-founder, Erica Barnell graduated from Cornell University with a dual degree in Biological Sciences and Applied Economics & Management. Erica is an MD/PhD candidate at the Washington University School of Medicine. In 2019, Erica completed her PhD at the McDonnell Genome Institute. Her thesis work surrounded the development of bioinformatic tools to alleviate the analysis bottleneck within precision oncology. Erica has published 19 peer-reviewed manuscripts, 11 abstracts with 4 platform presentations, and two book chapters within the oncology space. Erica conducted the original research to validate Geneoscopy’s stool extraction method and managed all feasibility studies for Geneoscopy’s colorectal cancer (CRC) screening test. Erica was responsible for existing engagement with the FDA, which includes holding three presubmission meetings and obtaining Breakthrough Device Designation for the lead CRC screening test. Erica is the lead inventor on all patents pertaining to Geneoscopy’s technology and is currently the site investigator on two IRB-approved protocols.
Connect on LinkedIn
Andrew Barnell
Chief Executive Officer
Co-founder of Geneoscopy, Andrew graduated from Cornell University with a Bachelor’s degree in Applied Economics & Management and a specialization in Finance. He received an MBA in Health Care Management and Entrepreneurial Management from The Wharton School. Andrew began his career as a financial analyst in J.P. Morgan’s healthcare investment banking group, working primarily on M&A and capital markets transactions. Andrew also worked as an associate at Lindsay Goldberg, a middle-market private equity firm focused on partnering with family-owned businesses.
Connect on LinkedIn
